Harvard Apparatus Regenerative Technology
(OTC) HRGN
Harvard Apparatus Regenerative Technology Financials at a Glance
Market Cap
$18.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$445.00K
Net Income (TTM)
-$6.81M
EPS (TTM)
-$0.40
P/E Ratio
-2.60
Dividend
$0.00
Beta (Volatility)
-0.17 (Low)
Dividend
$0.00
Beta (Volatility)
-0.17 (Low)
Price
$1.05
Volume
5
Open
$1.05
Price
$1.05
Volume
5
Open
$1.05
Previous Close
$1.05
Daily Range
$1.05 - $1.05
52-Week Range
$0.96 - $2.22
Estimated Earnings Date
May 18, 2026
Dividend
$0.00
Beta (Volatility)
-0.17 (Low)
Price
$1.05
Volume
5
Open
$1.05
Previous Close
$1.05
Daily Range
$1.05 - $1.05
52-Week Range
$0.96 - $2.22
Estimated Earnings Date
May 18, 2026
HRGN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Harvard Apparatus Regenerative Technology
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Jun Li He, CFA, MBA
Website
hregen.comHeadquarters
Holliston, MA 01746, US
HRGN Financials
Key Financial Metrics (TTM)
Gross Margin
-84.04%
Operating Margin
-1689.21%
Net Income Margin
-1530.56%
Return on Equity
-786.49%
Return on Capital
-606.61%
Return on Assets
-378.81%
Earnings Yield
-38.46%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$18.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
17.58M
Volume
5
Avg. Volume
1.13K
Financials (TTM)
Gross Profit
-$374.00K
Operating Income
-$7.52M
EBITDA
-$6.70M
Operating Cash Flow
-$4.01M
Capital Expenditure
$0.00
Free Cash Flow
-$4.01M
Cash & ST Invst.
$419.00K
Total Debt
$173.00K
Harvard Apparatus Regenerative Technology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$226.00K
N/A
Gross Profit
$20.00K
+160.6%
Gross Margin
8.85%
N/A
Market Cap
$18.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.31M
N/A
Employees
8
N/A
Net Income
-$1.60M
+3.5%
EBITDA
-$1.57M
+8.4%
Quarterly Fundamentals
Total Cash
$419.00K
-75.8%
Total Debt
$173.00K
-36.4%
Accounts Receivable
$16.00K
+300.0%
Inventory
$15.00K
-68.8%
Long Term Debt
$55.00K
-68.0%
Short Term Debt
$118.00K
+18.0%
Return on Assets
-3.79%
N/A
Return on Invested Capital
-51.14%
N/A
Free Cash Flow
-$937.00K
-23.6%
Operating Cash Flow
-$937.00K
-23.6%